1.Hemiparkisonism-Hemiatrophy with Presynaptic Dysfunction.
SulKi LEE ; Sang Won HA ; Cheon Mi JU
Journal of the Korean Neurological Association 2016;34(5):415-416
No abstract available.
2.Familial Creutzfeldt-Jakob Disease with M232R Mutation Progressed Slowly like Alzheimer's Disease.
SulKi LEE ; Hee Won BAE ; YoungSoon YANG
Dementia and Neurocognitive Disorders 2017;16(3):91-93
No abstract available.
Alzheimer Disease*
;
Creutzfeldt-Jakob Syndrome*
3.Atypical Hemorrhagic Brain Metastases Mimicking Cerebral Microbleeds
Sulki LEE ; Heewon BAE ; Unkyu YUN ; Inha HWANG ; Seung Min KIM
Journal of Neurocritical Care 2017;10(2):129-131
No abstract available.
Brain
;
Neoplasm Metastasis
4.Mild Encephalopathy with Reversible Splenial Lesion by Hypoglycemia: Magnetic Resonance Spectroscopy and Diffusion Tensor Image Findings
SulKi LEE ; Hee Won BAE ; Sang Won HA ; In Joong KIM ; Hyunkoo KANG
Journal of the Korean Neurological Association 2018;36(1):61-62
No abstract available.
Brain Diseases
;
Diffusion
;
Hypoglycemia
;
Magnetic Resonance Spectroscopy
5.Unilateral Sudden Deafness Accompanied by Short Circumferential Pontine Artery Territorial Infarction.
Sang Woo HAN ; Sang Won HA ; In Ha HWANG ; SulKi LEE ; Seung Min KIM ; YoungSun YANG ; Jeong Ho HAN ; Hyun Sang CHO
Journal of the Korean Neurological Association 2016;34(5):406-408
No abstract available.
Arteries*
;
Hearing Loss, Sudden*
;
Hearing Loss, Unilateral
;
Infarction*
;
Pons
7.Brain Abscess Caused by Vancomycin-Resistant Enterococci.
SulKi LEE ; Sang Won HA ; Un Kyu YUN ; In Ha WHANG ; Sang Woo HAN ; Seung Min KIM ; YoungSoon YANG ; Jeoung Ho HAN ; Inho OH ; Choon Kwan KIM
Journal of the Korean Neurological Association 2017;35(2):108-110
No abstract available.
Brain Abscess*
;
Brain*
;
Vancomycin-Resistant Enterococci*
8.Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
Yi-Te LEE ; Mohammad A. KARIM ; Hye Chung KUM ; Sulki PARK ; Nicole E. RICH ; Mazen NOUREDDIN ; Amit G. SINGAL ; Ju Dong YANG
Clinical and Molecular Hepatology 2023;29(2):453-464
Background/Aims:
Cirrhosis is the most important risk factor of hepatocellular carcinoma (HCC), and patients with cirrhosis are recommended to receive semiannual surveillance for early HCC detection. However, early cirrhosis is often asymptomatic and can go undiagnosed for years, leading to underuse of HCC surveillance in clinical practice. We characterized the frequency and associated factors of unrecognized cirrhosis in a national sample of patients with HCC from the United States.
Methods:
HCC patients aged 68 years and older, diagnosed during 2011 to 2015 were included from the SEERMedicare Linked Database. If cirrhosis was diagnosed within 6 months immediately preceding HCC diagnosis or after HCC diagnosis, cases were categorized as unrecognized cirrhosis. Factors associated with unrecognized cirrhosis were identified using logistic regression analyses. Factors associated with overall survival were evaluated using Cox regression analyses.
Results:
Among 5,098 HCC patients, 74.8% patients had cirrhosis. Among those with cirrhosis, 57.4% had unrecognized cirrhosis, with the highest proportion (76.3%) among those with NAFLD-related HCC. Male sex (aOR: 2.12, 95% CI: 1.83–2.46), non-Hispanic Black race (aOR: 1.93, 95% CI: 1.45–2.57), and NAFLD etiology (aOR: 4.46, 95% CI: 3.68–5.41) were associated with having unrecognized cirrhosis. Among NAFLD-related HCC patients, male sex (aOR: 2.32, 95% CI: 1.71–3.14) was associated with unrecognized cirrhosis. Unrecognized cirrhosis was independently associated with worse overall survival (aHR: 1.17, 95% CI: 1.08–1.27) compared to recognized cirrhosis.
Conclusions
Unrecognized cirrhosis is common in NAFLD-related HCC, particularly among male and Black patients, highlighting these groups as important intervention targets to improve HCC surveillance uptake and outcomes.
Result Analysis
Print
Save
E-mail